Pan MR - Search Results

1

Identification of CHD4-β1 integrin axis as a prognostic marker in triple-negative breast cancer using next-generation sequencing and bioinformatics.

Ou-Yang F, Pan MR, Chang SJ, Wu CC, Fang SY, Li CL, Hou MF, Luo CW. Ou-Yang F, et al. Among authors: pan mr. Life Sci. 2019 Dec 1;238:116963. doi: 10.1016/j.lfs.2019.116963. Epub 2019 Oct 19. Life Sci. 2019. PMID: 31639396

2

Cyclooxygenase-2 up-regulates CCR7 via EP2/EP4 receptor signaling pathways to enhance lymphatic invasion of breast cancer cells.

Pan MR, Hou MF, Chang HC, Hung WC. Pan MR, et al. J Biol Chem. 2008 Apr 25;283(17):11155-63. doi: 10.1074/jbc.M710038200. Epub 2008 Mar 4. J Biol Chem. 2008. PMID: 18319253 Free article.

3

Cyclooxygenase-2 up-regulates CCR7 expression via AKT-mediated phosphorylation and activation of Sp1 in breast cancer cells.

Chuang CW, Pan MR, Hou MF, Hung WC. Chuang CW, et al. Among authors: pan mr. J Cell Physiol. 2013 Feb;228(2):341-8. doi: 10.1002/jcp.24136. J Cell Physiol. 2013. PMID: 22718198

4

The histone methyltransferase G9a as a therapeutic target to override gemcitabine resistance in pancreatic cancer.

Pan MR, Hsu MC, Luo CW, Chen LT, Shan YS, Hung WC. Pan MR, et al. Oncotarget. 2016 Sep 20;7(38):61136-61151. doi: 10.18632/oncotarget.11256. Oncotarget. 2016. PMID: 27531902 Free PMC article.

5

β1 Integrin as a Prognostic and Predictive Marker in Triple-Negative Breast Cancer.

Yin HL, Wu CC, Lin CH, Chai CY, Hou MF, Chang SJ, Tsai HP, Hung WC, Pan MR, Luo CW. Yin HL, et al. Among authors: pan mr. Int J Mol Sci. 2016 Aug 31;17(9):1432. doi: 10.3390/ijms17091432. Int J Mol Sci. 2016. PMID: 27589736 Free PMC article.

6

G9a governs colon cancer stem cell phenotype and chemoradioresistance through PP2A-RPA axis-mediated DNA damage response.

Luo CW, Wang JY, Hung WC, Peng G, Tsai YL, Chang TM, Chai CY, Lin CH, Pan MR. Luo CW, et al. Among authors: pan mr. Radiother Oncol. 2017 Sep;124(3):395-402. doi: 10.1016/j.radonc.2017.03.002. Epub 2017 Mar 25. Radiother Oncol. 2017. PMID: 28351524

7

CHD4 as a Potential Biomarker in Differentiating Between Cellular Schwannoma and Malignant Peripheral Nerve Sheath Tumor.

Wu CC, Pan MR, Wei YC, Lin CH, Yang SF, Tsai HP, Luo CW, Chai CY. Wu CC, et al. Among authors: pan mr. Appl Immunohistochem Mol Morphol. 2018 Nov/Dec;26(10):775-780. doi: 10.1097/PAI.0000000000000522. Appl Immunohistochem Mol Morphol. 2018. PMID: 28549031

8

The NuRD complex-mediated p21 suppression facilitates chemoresistance in BRCA-proficient breast cancer.

Hou MF, Luo CW, Chang TM, Hung WC, Chen TY, Tsai YL, Chai CY, Pan MR. Hou MF, et al. Among authors: pan mr. Exp Cell Res. 2017 Oct 15;359(2):458-465. doi: 10.1016/j.yexcr.2017.08.029. Epub 2017 Aug 24. Exp Cell Res. 2017. PMID: 28842166

9

CHD4-mediated loss of E-cadherin determines metastatic ability in triple-negative breast cancer cells.

Luo CW, Wu CC, Chang SJ, Chang TM, Chen TY, Chai CY, Chang CL, Hou MF, Pan MR. Luo CW, et al. Among authors: pan mr. Exp Cell Res. 2018 Feb 1;363(1):65-72. doi: 10.1016/j.yexcr.2017.12.032. Epub 2018 Jan 3. Exp Cell Res. 2018. PMID: 29305962

10

Cell Motility Facilitated by Mono(2-ethylhexyl) Phthalate via Activation of the AKT-β-Catenin-IL-8 Axis in Colorectal Cancer.

Luo CW, Hsiao IL, Wang JY, Wu CC, Hung WC, Lin YH, Chen TY, Hsu YC, Cheng TL, Pan MR. Luo CW, et al. Among authors: pan mr. J Agric Food Chem. 2018 Sep 19;66(37):9635-9644. doi: 10.1021/acs.jafc.8b03558. Epub 2018 Sep 6. J Agric Food Chem. 2018. PMID: 30188700

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

74 results

Search Page

Filters